| Dr Garth Robert Smith, MD | |
|
2003 Medical Parkway, Suite 400, Annapolis, MD 21401-3088 | |
| (410) 573-2530 | |
| (410) 573-2536 |
| Full Name | Dr Garth Robert Smith |
|---|---|
| Gender | Male |
| Speciality | Hand Surgery |
| Experience | 34 Years |
| Location | 2003 Medical Parkway, Annapolis, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437114303 | NPI | - | NPPES |
| G04704 | Other | MD | UPIN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XS0106X | Orthopaedic Surgery - Hand Surgery | D50526 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Anne Arundel Medical Center | Annapolis, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Centers For Advanced Orthopaedics Llc | 8123260981 | 476 |
| Centers For Advanced Orthopaedics Llc | 8123260981 | 476 |
News Archive
Interim data from a prospective Investigator Initiated Trial presented today at the ECTS, the 37th European Symposium on Calcified Tissues, in Glasgow, demonstrates that EVISTA (raloxifene 60mg; once-daily, distributed in 34 countries by DAIICHI SANKYO), indicated for the treatment and prevention of osteoporosis in postmenopausal women, improves bone quality as measured by the high-resolution peripheral quantitative computed tomography.
A new American Cancer Society study finds that despite significant drops in smoking rates, cigarettes continue to cause about three in ten cancer deaths in the United States. The study, appearing in the Annals of Epidemiology, concludes that efforts to reduce smoking prevalence as rapidly as possible should be a top priority for the U.S. public health efforts to prevent cancer deaths.
The New Orleans Times-Picayune reports that a "health care overhaul faces a tough sell among the Louisiana delegation:" "Sen. Mary Landrieu, D-La., said the bill pending ... isn't aggressive enough in trying to curb rising health care costs. But she also said that doing nothing is not an option with so many Louisiana families and small businesses unable to afford health coverage.
Naurex Inc. today announced that the U.S. Food and Drug Administration has granted Fast Track designation to the investigation of GLYX-13, the company's rapid-acting antidepressant in Phase 2 clinical development, as adjunctive therapy in major depressive disorder.
› Verified 6 days ago
| Entity Name | Centers For Advanced Orthopaedics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487093167 PECOS PAC ID: 8123260981 Enrollment ID: O20131024001780 |
News Archive
Interim data from a prospective Investigator Initiated Trial presented today at the ECTS, the 37th European Symposium on Calcified Tissues, in Glasgow, demonstrates that EVISTA (raloxifene 60mg; once-daily, distributed in 34 countries by DAIICHI SANKYO), indicated for the treatment and prevention of osteoporosis in postmenopausal women, improves bone quality as measured by the high-resolution peripheral quantitative computed tomography.
A new American Cancer Society study finds that despite significant drops in smoking rates, cigarettes continue to cause about three in ten cancer deaths in the United States. The study, appearing in the Annals of Epidemiology, concludes that efforts to reduce smoking prevalence as rapidly as possible should be a top priority for the U.S. public health efforts to prevent cancer deaths.
The New Orleans Times-Picayune reports that a "health care overhaul faces a tough sell among the Louisiana delegation:" "Sen. Mary Landrieu, D-La., said the bill pending ... isn't aggressive enough in trying to curb rising health care costs. But she also said that doing nothing is not an option with so many Louisiana families and small businesses unable to afford health coverage.
Naurex Inc. today announced that the U.S. Food and Drug Administration has granted Fast Track designation to the investigation of GLYX-13, the company's rapid-acting antidepressant in Phase 2 clinical development, as adjunctive therapy in major depressive disorder.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Garth Robert Smith, MD 2003 Medical Parkway, Suite 400, Annapolis, MD 21401-3088 Ph: (410) 573-2530 | Dr Garth Robert Smith, MD 2003 Medical Parkway, Suite 400, Annapolis, MD 21401-3088 Ph: (410) 573-2530 |
News Archive
Interim data from a prospective Investigator Initiated Trial presented today at the ECTS, the 37th European Symposium on Calcified Tissues, in Glasgow, demonstrates that EVISTA (raloxifene 60mg; once-daily, distributed in 34 countries by DAIICHI SANKYO), indicated for the treatment and prevention of osteoporosis in postmenopausal women, improves bone quality as measured by the high-resolution peripheral quantitative computed tomography.
A new American Cancer Society study finds that despite significant drops in smoking rates, cigarettes continue to cause about three in ten cancer deaths in the United States. The study, appearing in the Annals of Epidemiology, concludes that efforts to reduce smoking prevalence as rapidly as possible should be a top priority for the U.S. public health efforts to prevent cancer deaths.
The New Orleans Times-Picayune reports that a "health care overhaul faces a tough sell among the Louisiana delegation:" "Sen. Mary Landrieu, D-La., said the bill pending ... isn't aggressive enough in trying to curb rising health care costs. But she also said that doing nothing is not an option with so many Louisiana families and small businesses unable to afford health coverage.
Naurex Inc. today announced that the U.S. Food and Drug Administration has granted Fast Track designation to the investigation of GLYX-13, the company's rapid-acting antidepressant in Phase 2 clinical development, as adjunctive therapy in major depressive disorder.
› Verified 6 days ago
Dr. Peter Norman Ove, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 Medical Pkwy, Suite 101, Annapolis, MD 21401 Phone: 410-268-8862 Fax: 410-280-4701 | |
Garrett John Lynch, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2003 Medical Parkway, Suite 400, Annapolis, MD 21401 Phone: 410-573-2530 Fax: 410-573-2536 | |
Dr. Louis Joseph Ruland Iii, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2003 Medical Parkway, Suite 400, Annapolis, MD 21401 Phone: 410-573-2530 Fax: 410-573-2536 | |
Dr. Justin L Cashman Iii, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 130 Admiral Cochrane Dr, Suite 303, Annapolis, MD 21401 Phone: 410-571-4338 Fax: 410-881-0159 | |
Dr. Marc F Brassard, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 Medical Pkwy, Suite 101, Annapolis, MD 21401 Phone: 410-268-8862 Fax: 410-280-4701 | |
Dr. Robert M Verklin Jr., MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 Medical Pkwy, Suite 101, Annapolis, MD 21401 Phone: 410-268-8862 Fax: 410-280-4701 | |
Dr. James Macdonald, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 Medical Pkwy, Suite 101, Annapolis, MD 21401 Phone: 410-268-8862 Fax: 410-280-4701 |